TELIX Pharmaceuticals Ltd (TLX) — Free Cash Flow Generation Index
TELIX Pharmaceuticals Ltd (TLX) has a Free Cash Flow Generation Index of 0.60x as of June 2025. Free cash flow of AU$16.84 Million represents 1% of operating cash flow (AU$27.98 Million). Explore how much does TELIX Pharmaceuticals Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
TELIX Pharmaceuticals Ltd Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for TELIX Pharmaceuticals Ltd across 3 annual periods. For the full cash flow conversion analysis, see TELIX Pharmaceuticals Ltd (TLX) cash flow conversion.
Annual Free Cash Flow Generation for TELIX Pharmaceuticals Ltd (2020–2024)
Year-by-year Free Cash Flow Generation Index for TELIX Pharmaceuticals Ltd. Check how aggressively does TELIX Pharmaceuticals Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | AU$9.00 Million | AU$43.03 Million | AU$34.03 Million | ▼ -61.8% |
| 2023 | 0.55x | AU$13.09 Million | AU$23.88 Million | AU$10.79 Million | ▼ -34.4% |
| 2020 | 0.84x | AU$1.64 Million | AU$1.96 Million | AU$322.00K | — |